Working... Menu
Trial record 95 of 4293 for:    bone tumors AND NOT metastatic

National Swiss Sarcoma Cohort Study (SwissSARCOS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02775799
Recruitment Status : Terminated (Principal Investigator has left the Institution)
First Posted : May 18, 2016
Last Update Posted : October 2, 2018
University of Bern
Information provided by (Responsible Party):
Balgrist University Hospital

Brief Summary:
Registration of all sarcoma patients treated at a specialized sarcoma center in Switzerland.

Condition or disease Intervention/treatment
Sarcoma Neoplasm of Bone Neoplasms Soft Tissue Sarcoma Soft Tissue Neoplasm Sarcoma of Bone Other: Registration

  Show Detailed Description

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 20 Years
Official Title: Prospective Multi-center National Swiss Sarcoma Cohort Study
Study Start Date : April 2015
Actual Primary Completion Date : July 2018
Actual Study Completion Date : July 2018

Resource links provided by the National Library of Medicine

Intervention Details:
  • Other: Registration
    Registration according to approved data sets

Primary Outcome Measures :
  1. Overall survival rate [ Time Frame: up to 20 years after first line treatment ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients diagnosed with histo- pathological proven sarcoma

Inclusion Criteria:

  • all primary bone and soft tissue sarcoma defined by th WHO classification 2013

Exclusion Criteria:

  • all non- primary sarcomas
  • patient's wish

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02775799

Layout table for location information
Balgrist University Hospital
Zurich, Switzerland, 8008
Sponsors and Collaborators
Balgrist University Hospital
University of Bern
Layout table for investigator information
Study Chair: Bruno Fuchs, MD PhD Balgrist UH

Additional Information:

Layout table for additonal information
Responsible Party: Balgrist University Hospital Identifier: NCT02775799     History of Changes
Other Study ID Numbers: 2014-0394
First Posted: May 18, 2016    Key Record Dates
Last Update Posted: October 2, 2018
Last Verified: September 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: Assessed data shall be shared with the National Institute for Cancer Epidemiology an Registration and the cantonal cancer registers

Additional relevant MeSH terms:
Layout table for MeSH terms
Soft Tissue Neoplasms
Bone Neoplasms
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type
Neoplasms by Site
Bone Diseases
Musculoskeletal Diseases